628 related articles for article (PubMed ID: 25359125)
21. Load-mediated downregulation of myostatin mRNA is not sufficient to promote myofiber hypertrophy in humans: a cluster analysis.
Kim JS; Petrella JK; Cross JM; Bamman MM
J Appl Physiol (1985); 2007 Nov; 103(5):1488-95. PubMed ID: 17673556
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in understanding resistance exercise training-induced skeletal muscle hypertrophy in humans.
Joanisse S; Lim C; McKendry J; Mcleod JC; Stokes T; Phillips SM
F1000Res; 2020; 9():. PubMed ID: 32148775
[TBL] [Abstract][Full Text] [Related]
23. The mechanistic and ergogenic effects of phosphatidic acid in skeletal muscle.
Shad BJ; Smeuninx B; Atherton PJ; Breen L
Appl Physiol Nutr Metab; 2015 Dec; 40(12):1233-41. PubMed ID: 26566242
[TBL] [Abstract][Full Text] [Related]
24. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification.
Pallafacchina G; Calabria E; Serrano AL; Kalhovde JM; Schiaffino S
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9213-8. PubMed ID: 12084817
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of mechanical overload-induced skeletal muscle hypertrophy: current understanding and future directions.
Roberts MD; McCarthy JJ; Hornberger TA; Phillips SM; Mackey AL; Nader GA; Boppart MD; Kavazis AN; Reidy PT; Ogasawara R; Libardi CA; Ugrinowitsch C; Booth FW; Esser KA
Physiol Rev; 2023 Oct; 103(4):2679-2757. PubMed ID: 37382939
[TBL] [Abstract][Full Text] [Related]
26. Skeletal muscle hypertrophy and atrophy signaling pathways.
Glass DJ
Int J Biochem Cell Biol; 2005 Oct; 37(10):1974-84. PubMed ID: 16087388
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of work-induced hypertrophy of skeletal muscle.
Goldberg AL; Etlinger JD; Goldspink DF; Jablecki C
Med Sci Sports; 1975; 7(3):185-98. PubMed ID: 128681
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
29. mTORC1 and the regulation of skeletal muscle anabolism and mass.
Adegoke OA; Abdullahi A; Tavajohi-Fini P
Appl Physiol Nutr Metab; 2012 Jun; 37(3):395-406. PubMed ID: 22509811
[TBL] [Abstract][Full Text] [Related]
30. REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy.
Britto FA; Begue G; Rossano B; Docquier A; Vernus B; Sar C; Ferry A; Bonnieu A; Ollendorff V; Favier FB
Am J Physiol Endocrinol Metab; 2014 Dec; 307(11):E983-93. PubMed ID: 25315696
[TBL] [Abstract][Full Text] [Related]
31. The metabolic and temporal basis of muscle hypertrophy in response to resistance exercise.
Brook MS; Wilkinson DJ; Smith K; Atherton PJ
Eur J Sport Sci; 2016 Sep; 16(6):633-44. PubMed ID: 26289597
[TBL] [Abstract][Full Text] [Related]
32. Myogenic, matrix, and growth factor mRNA expression in human skeletal muscle: effect of contraction intensity and feeding.
Agergaard J; Reitelseder S; Pedersen TG; Doessing S; Schjerling P; Langberg H; Miller BF; Aagaard P; Kjaer M; Holm L
Muscle Nerve; 2013 May; 47(5):748-59. PubMed ID: 23519763
[TBL] [Abstract][Full Text] [Related]
33. Role of IGF-I in follistatin-induced skeletal muscle hypertrophy.
Barbé C; Kalista S; Loumaye A; Ritvos O; Lause P; Ferracin B; Thissen JP
Am J Physiol Endocrinol Metab; 2015 Sep; 309(6):E557-67. PubMed ID: 26219865
[TBL] [Abstract][Full Text] [Related]
34. Resistance exercise, muscle loading/unloading and the control of muscle mass.
Baar K; Nader G; Bodine S
Essays Biochem; 2006; 42():61-74. PubMed ID: 17144880
[TBL] [Abstract][Full Text] [Related]
35. Blood flow restricted and traditional resistance training performed to fatigue produce equal muscle hypertrophy.
Farup J; de Paoli F; Bjerg K; Riis S; Ringgard S; Vissing K
Scand J Med Sci Sports; 2015 Dec; 25(6):754-63. PubMed ID: 25603897
[TBL] [Abstract][Full Text] [Related]
36. Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy.
Philippou A; Halapas A; Maridaki M; Koutsilieris M
J Musculoskelet Neuronal Interact; 2007; 7(3):208-18. PubMed ID: 17947802
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms regulating skeletal muscle growth and atrophy.
Schiaffino S; Dyar KA; Ciciliot S; Blaauw B; Sandri M
FEBS J; 2013 Sep; 280(17):4294-314. PubMed ID: 23517348
[TBL] [Abstract][Full Text] [Related]
38. Resistance exercise training modulates acute gene expression during human skeletal muscle hypertrophy.
Nader GA; von Walden F; Liu C; Lindvall J; Gutmann L; Pistilli EE; Gordon PM
J Appl Physiol (1985); 2014 Mar; 116(6):693-702. PubMed ID: 24458751
[TBL] [Abstract][Full Text] [Related]
39. Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women.
Kim JS; Cross JM; Bamman MM
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1110-9. PubMed ID: 15644458
[TBL] [Abstract][Full Text] [Related]
40. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy.
Kalista S; Schakman O; Gilson H; Lause P; Demeulder B; Bertrand L; Pende M; Thissen JP
Endocrinology; 2012 Jan; 153(1):241-53. PubMed ID: 22087027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
